Success Metrics

Clinical Success Rate
87.5%

Based on 21 completed trials

Completion Rate
88%(21/24)
Active Trials
3(9%)
Results Posted
38%(8 trials)
Terminated
3(9%)

Phase Distribution

Ph phase_2
13
37%
Ph phase_4
6
17%
Ph not_applicable
1
3%
Ph phase_3
15
43%

Phase Distribution

0

Early Stage

13

Mid Stage

21

Late Stage

Phase Distribution35 total trials
Phase 2Efficacy & side effects
13(37.1%)
Phase 3Large-scale testing
15(42.9%)
Phase 4Post-market surveillance
6(17.1%)
N/ANon-phased studies
1(2.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

21 of 24 finished

Non-Completion Rate

12.5%

3 ended early

Currently Active

3

trials recruiting

Total Trials

35

all time

Status Distribution
Active(4)
Completed(21)
Terminated(3)
Other(7)

Detailed Status

Completed21
unknown7
Terminated3
Recruiting2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
35
Active
3
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 213 (37.1%)
Phase 315 (42.9%)
Phase 46 (17.1%)
N/A1 (2.9%)

Trials by Status

unknown720%
not_yet_recruiting13%
terminated39%
recruiting26%
active_not_recruiting13%
completed2160%

Recent Activity

Clinical Trials (35)

Showing 20 of 35 trialsScroll for more
NCT04547049Phase 3

A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies

Active Not Recruiting
NCT06800157Phase 2

Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis

Completed
NCT07185373Phase 2

Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL

Not Yet Recruiting
NCT05921305Phase 3

Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD

Recruiting
NCT04960644Phase 3

MTX and Steroid as First-line Therapy for aGVHD

Completed
NCT05040464Phase 3

Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial

Recruiting
NCT03301883Phase 4

A Study of Tocilizumab in Chinese Participants With Systemic Juvenile Idiopathic Arthritis (sJIA)

Completed
NCT03155347Phase 3

An Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) Therapy

Completed
NCT02837978Phase 4

The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term Treatment

Completed
NCT03855007Phase 4

The Clinical Efficacy and Safety of Iguratimod in RA and Early RA Patients for 6 Months Treatment

Completed
NCT03096275Phase 3

Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis

Completed
NCT02270632Phase 2

A Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of F8IL10 (Dekavil) in Patients With Active RA Receiving MTX

Terminated
NCT04688021Phase 2

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

Unknown
NCT02200978Phase 4

A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia

Completed
NCT02043587Phase 2

Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma

Terminated
NCT05313061Phase 3

MTX Hold During Covid-19 Booster

Unknown
NCT02889796Phase 3

Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Completed
NCT02886728Phase 3

Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy

Completed
NCT02504671Phase 2

Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis

Completed
NCT02799472Phase 2

Mechanistic Study of GSK3196165 Plus Methotrexate (MTX) in Subjects With Active Rheumatoid Arthritis

Completed

Drug Details

Intervention Type
DRUG
Total Trials
35